GSK competitorsClear all

GSK's top competitors include Johnson & Johnson, Roche, AstraZeneca, Takeda Pharmaceutical, Bayer and Eli Lilly.
GSK
GSK
GSK (GlaxoSmithKline) is a science-led healthcare company.
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Roche
Roche
Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.
AstraZeneca
AstraZeneca
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Takeda Pharmaceutical
Takeda Pharmaceutical
Takeda Pharmaceutical is a biopharmaceutical company.
Bayer
Bayer
Bayer is a global life science company specializing in healthcare and nutrition.
Eli Lilly
Eli Lilly
Eli Lilly and Company is a company that discovers, develops, manufactures, and markets pharmaceutical products.
Founding Date
Founding Date
2000
Founding Date
1886
Founding Date
1896
Founding Date
1999
Founding Date
1781
Founding Date
1863
Founding Date
1876
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Brentford, GB HQ
Tirane, AL
Boudouaou, DZ
Victoria, AR
Abbotsford, AU
Boronia, AU
Ermington, AU
see more
Locations
New Brunswick, US HQ
Buenos Aires, AR
Chippendale, AU
Wien, AT
Minsk, BY
Beerse, BE
Brussel, BE
see more
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
North Ryde, AU
Sydney, AU
Wien, AT
Wien, AT
see more
Locations
Cambridge, GB HQ
Alger, DZ
Buenos Aires, AR
Haedo, AR
Macquarie Park, AU
Macquarie Park, AU
North Ryde, AU
see more
Locations
Tokyo, JP HQ
The Rocks, AU
Linz, AT
Wien, AT
Sint Jans Molenbeek, BE
Santo Amaro, BR
Toronto, CA
see more
Locations
Leverkusen, DE HQ
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
Dhaka, BD
see more
Locations
Indianapolis, US HQ
Melrose Park, AU
Wien, AT
Brussel, BE
São Paulo, BR
Toronto, CA
Las Condes, CL
see more
Employees
Employees
99,4374% increase
Employees
132,2002% decrease
Employees
97,7353% increase
Employees
70,6009% increase
Employees
47,4954% decrease
Employees
101,1683% decrease
Employees
33,62513% decrease
Valuation ($)
Valuation ($)
94.6 b
Valuation ($)
427.5 b
Valuation ($)
N/A
Valuation ($)
137.8 b
Valuation ($)
54.1 b
Valuation ($)
63.8 b
Valuation ($)
192.5 b
Twitter followers
Twitter followers
216 k
Twitter followers
214.5 k
Twitter followers
227.8 k
Twitter followers
230.5 k
Twitter followers
N/A
Twitter followers
177.3 k
Twitter followers
126.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
36
Number of tweets (last 30 days)
21
Number of tweets (last 30 days)
31
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
41
Number of tweets (last 30 days)
30
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
21.2
Average likes per tweet (last 30 days)
11.6
Average likes per tweet (last 30 days)
21
Average likes per tweet (last 30 days)
172.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
15.9
Average likes per tweet (last 30 days)
10
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
80.56%
Percentage of tweets with engagement (last 30 days)
61.9%
Percentage of tweets with engagement (last 30 days)
80.65%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
68.29%
Percentage of tweets with engagement (last 30 days)
40%
Alexa Website Rank
Alexa Website Rank
35293
Alexa Website Rank
24994
Alexa Website Rank
65169
Alexa Website Rank
93263
Alexa Website Rank
192980
Alexa Website Rank
83024
Alexa Website Rank
142814
Employee Rating
Employee Rating
4
Employee Rating
4.1
Employee Rating
N/A
Employee Rating
4.2
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.9

Financial

Revenue (est.)
Revenue (est.)
£33.8b (FY, 2019)
Revenue (est.)
$82.1b (FY, 2019)
Revenue (est.)
CHF63.8b (FY, 2019)
Revenue (est.)
$24.4b (FY, 2019)
Revenue (est.)
¥3.3t (FY, 2020)
Revenue (est.)
€43.5b (FY, 2019)
Revenue (est.)
$22.3b (FY, 2019)
Cost of goods
Cost of goods
£11.9b (FY, 2019)
Cost of goods
$27.6b (FY, 2019)
Cost of goods
CHF18.4b (FY, 2019)
Cost of goods
$4.9b (FY, 2019)
Cost of goods
¥1.1t (FY, 2020)
Cost of goods
€17.5b (FY, 2019)
Cost of goods
$4.7b (FY, 2019)
Gross profit
Gross profit
£21.9b (FY, 2019)
Gross profit
$54.5b (FY, 2019)
Gross profit
CHF45.4b (FY, 2019)
Gross profit
$19.5b (FY, 2019)
Gross profit
¥2.2t (FY, 2020)
Gross profit
€26.1b (FY, 2019)
Gross profit
$17.6b (FY, 2019)
Net income
Net income
£5.3b (FY, 2019)
Net income
$15.1b (FY, 2019)
Net income
CHF14.1b (FY, 2019)
Net income
$1.2b (FY, 2019)
Net income
¥44.3b (FY, 2020)
Net income
€2.4b (FY, 2019)
Net income
$8.3b (FY, 2019)

Operating

Countries
Countries
N/A
Countries
60 (FY, 2018)
Countries
N/A
Countries
100 (FY, 2019)
Countries
N/A
Countries
153 (FY, 2018)
Countries
120 (FY, 2019)
Filed Trials Products (Oncology)
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
3 (Dec, 2020)
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
8 (Oct, 2020)
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
N/A
Manufacturing Facilities
Manufacturing Facilities
87 (FY, 2016)
Manufacturing Facilities
97 (FY, 2019)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Patients Included in Clinical Trials
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
282.5 k (FY, 2019)
Patients Included in Clinical Trials
33 k (FY, 2017)
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Phase I Trials Products
Phase I Trials Products
12 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
27 (FY, 2019)
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
43 (Dec, 2020)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
1 (Jul, 2019)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
12 (Jan, 2020)
Phase II Trials Products
9 (FY, 2019)
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
7 (Dec, 2020)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
8 (Oct, 2019)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
14 (FY, 2019)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
9 (Jan, 2020)
Phase III Trials Products
15 (FY, 2019)
Phase III Trials Products (Neuroscience)
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Neuroscience)
2 (Dec, 2020)
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Neuroscience)
1 (Feb, 2020)
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
26 (Dec, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
5 (Oct, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
167 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
66 (FY, 2016)
Suppliers
Suppliers
N/A
Suppliers
3.5 k (Jun, 2018)
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
86.4 k (FY, 2019)
Suppliers
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 2.8b
Total funding raised
$ 1b
Total funding raised
$ 57.8m
Total funding raised
$ 3.5b
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Johnson & Johnson
HQ
New Brunswick, US
Employees
132,200↓ 2% decrease

Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field.

View company
Roche
HQ
Basel, CH
Employees
97,735↑ 3% increase

Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.

View company
AstraZeneca
HQ
Cambridge, GB
Employees
70,600↑ 9% increase

AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.

View company
Takeda Pharmaceutical
HQ
Tokyo, JP
Employees
47,495↓ 4% decrease

Takeda Pharmaceutical is a biopharmaceutical company.

View company